Mr. Speaker, I am pleased to rise in this debate and ask my colleague about something that affects my community, and I am sure hers, and that is medical research in this country.
We have invested much in our peer reviewed research through the granting councils. Medical research is big in my community, with five research institutes, and the impact of not having sufficient funds to do the ongoing research that is used throughout Canada and even throughout the world in effect will contribute down the road to us losing these highly skilled individuals in our communities.
On another point, I would like to raise the issue that this budget takes away the harm reduction strategy that has been there since the time before Liberal governments, back into previous incarnations of other governments. That has been taken out of the way that drug policy is done in this budget.
I would like the hon. member's comments on both of those areas.